Error loading player: No playable sources found
2520
H pylori and Gastric Cancer - Updates in Pathogenesis and Diagnosis
Date
May 18, 2024
General
Tracks
Related Products
FDA Town Hall
SOCIETY: AGA The AGA-FDA Town Hall provides health care professionals, clinical trial investigators, and other interested stakeholders an opportunity to hear directly from FDA representatives about the agency's thinking behind recent approvals, safety signals, guidance documents, and boxed warnings…
IL-17 SIGNALING REDUCES GASTRIC CARCINOGENESIS BY ALTERING FUNCTION OF THE HELICOBACTER CAG TYPE 4 SECRETION SYSTEM AND SUPPRESSING LRIG1 ACTIVATION
_Helicobacter pylori_ is the strongest risk factor for gastric cancer; however, only a minority of infected individuals develop disease. One microbial cancer-linked locus is the _cag_ type 4 secretion system (_cag_T4SS), which translocates the oncoprotein CagA into host cells…
PANEL DISCUSSION
40 years after the organism was first recognized and grown in culture, Helicobacter pylori infections are still commonly encountered in practice,. This symposium will focus on several areas that remain unresolved to this day - including how best to manage H…